International experience of vedolizumab in primary sclerosing cholangitis and inflammatory bowel disease (Gastroenterology, 2018)

(untitled) - Williamson, K; Lytvyak, E; De Krijger, M; Trivedi, P; Estes, D; Yu, L; Pratt, D; De Vries, A; Daretti, L; Liu, C; Bowlus, C; Marschall, H; et al.